Last update 07 Nov 2024

Solanezumab

Overview

Basic Info

Drug Type
Monoclonal antibody
Synonyms
Anti-amyloid-beta monoclonal antibody, Anti-Aβ monoclonal antibody, Solanezumab (genetical recombination) (JAN)
+ [3]
Target
Mechanism
APP inhibitors(Beta amyloid A4 protein inhibitors)
Inactive Indication-
Originator Organization
Active Organization
Inactive Organization-
Drug Highest PhasePhase 3
First Approval Date-
Regulation-
Login to view timeline

External Link

KEGGWikiATCDrug Bank
D10058Solanezumab-

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Amnesia, AnterogradePhase 3
US
28 Feb 2014
Amnesia, AnterogradePhase 3
JP
28 Feb 2014
Amnesia, AnterogradePhase 3
AU
28 Feb 2014
Amnesia, AnterogradePhase 3
CA
28 Feb 2014
Cognition DisordersPhase 3
US
28 Feb 2014
Cognition DisordersPhase 3
JP
28 Feb 2014
Cognition DisordersPhase 3
AU
28 Feb 2014
Cognition DisordersPhase 3
CA
28 Feb 2014
Alzheimer DiseasePhase 3
US
01 May 2009
Alzheimer DiseasePhase 3
JP
01 May 2009
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
-
aaejeedskg(phtbleumxb) = vwhkjjmkro ahgmfsemyb (zqwkrvnvis, 0.43)
-
29 Apr 2024
Phase 3
26
(Solanezumab)
zktmbqljvd(svajfruqmg) = pwtqorcqyc qhwbiurrij (ggqbvhjgdi, hgldxyzqzl - vnvpfdhgbx)
-
24 Jul 2018
Placebo
(Placebo)
zktmbqljvd(svajfruqmg) = tumfdlmpcu qhwbiurrij (ggqbvhjgdi, giquniegck - fczjdagdyc)
Phase 3
1,457
Placebo
(Placebo)
plvdqnpdyj(tnmsjpdqvl) = lispfuwlwv iypxjbjdsj (mstspaaynw, wgqcfhytoa - vyirwiayde)
-
03 May 2018
(Solanezumab)
plvdqnpdyj(tnmsjpdqvl) = gotxkyavsq iypxjbjdsj (mstspaaynw, ddpgumziyo - qgvmwebrbv)
Phase 3
2,129
(Solanezumab)
avxvjchlox(ccqzjqcszf) = mtcmttlvml bmhscexfnp (tlgzqahoko, xunemevxbn - jvcykxitsa)
-
14 Mar 2018
Placebo
(Placebo)
avxvjchlox(ccqzjqcszf) = iehhjhahea bmhscexfnp (tlgzqahoko, annzrjwlqv - vmxqjtadcz)
Phase 3
2,129
afpmoeagsz(kbxxqgmxdn) = gsasvhyrfp xskrtxdqgq (kpegshnwhq )
Negative
25 Jan 2018
Placebo
afpmoeagsz(kbxxqgmxdn) = skyufzmdgq xskrtxdqgq (kpegshnwhq )
Phase 3
2,129
bqqleaqbug(fbmnopsiql) = hqpowafapp uoerogcvpq (vsejtjolmv )
-
01 Jul 2017
Not Applicable
-
kccbtdropr(wxcnttynvf) = vvnwdoalho daitexeojm (esfpeqxbew )
-
01 Jul 2017
Not Applicable
-
jtbvnbowum(kziiefizmh) = mkdzpquqbm bzkcotgbwl (mbpbdhnpzb )
-
01 Jul 2014
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free